Revascularization strategies in cardiogenic shock after acute myocardial infarction

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Coronary Syndromes

Background:

• Coronary revascularization improves survival in patients with myocardial infarction (MI) and cardiogenic shock.
• Percutaneous coronary intervention (PCI) is the primary revascularization method used.
• This review covers indications, PCI vs. bypass surgery, access sites, multivessel disease strategies, and antithrombotic therapy.

Purpose of the Study:

• To review current practices and evidence regarding coronary revascularization in patients with acute myocardial infarction and cardiogenic shock.
• To discuss the optimal strategy for revascularization, including the choice between PCI and bypass surgery.
• To highlight recent findings and evolving trends in managing this high-risk patient population.

Main Methods:

• Review of current literature and clinical trial data, including the CULPRIT-SHOCK trial.
• Discussion of established guidelines and emerging evidence for revascularization strategies.
• Analysis of factors influencing treatment decisions, such as patient presentation and coronary anatomy.

Main Results:

• The CULPRIT-SHOCK trial demonstrated that PCI should primarily target the culprit lesion in infarct-related cardiogenic shock.
• Routine treatment of non-culprit lesions in the emergency setting is not recommended based on current evidence.
• Radial access for PCI is increasingly favored in the cardiogenic shock population, though randomized data are pending.
• Cardiac surgery has a limited but essential role in specific cases.

Conclusions:

• Coronary revascularization is crucial for the early management of acute MI with cardiogenic shock.
• A strategy focusing on culprit lesion-only PCI is the standard approach for multivessel disease in this setting.
• Current evidence supports a tailored approach to revascularization, emphasizing the culprit lesion and considering radial access.